Melanoma  

  • S1320:  Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery

     

For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360-788-8238.​